X

Company profile for CLL Pharma FR 06299 Nice Cedex 3

CLL Pharma FR 06299 Nice Cedex 3

CLL PHARMA FR 06299 NICE CEDEX 3

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

APIs // Active Pharmaceutical Ingredients

1 APIs, 1 CEP/COS

DEVELOPMENTS

No Content

Contact Supplier

Related Companies

The Chairman's message In 1995, when CLL PHARMA was founded on the French Riviera, we set ourselves the dual target of providing movers in the pharmaceutical world, and patients, with access to: - drugs providing very high levels of quality, safety and efficacy together with a more favourable price structure - innovative galenical formulations able to producing better treatment acceptance and compliance. Today, with 50 ma...

The Chairman's message In 1995, when CLL PHARMA was founded on the French Riviera, we set ourselves the dual target of providing movers in the pharmaceutical world, and patients, with access to: - drugs providing very high levels of quality, safety and efficacy together with a more favourable price structure - innovative galenical formulations able to producing better treatment acceptance and compliance. Today, with 50 marketing authorizations, over 30 development projects and 80 international patents involving 5 drug delivery technologies, we can only feel proud of the progress made and confident of what we may yet do. We would like to take the opportunity to thank all those people, worldwide, who have placed and are placing their trust in us. Claude LARUELLE Who we are CLL PHARMA is a pharmaceutical laboratory founded in 1995, specializing in the development of new drugs with high added value: - generic drugs, and - new galenical formulations until marketing authorization (M.A.). Distribution rights are granted under licence to major pharmaceutical companies. CLL PHARMA, a private, independent company, is the leader of its market sector in France. CLL PHARMA owns a portfolio of 50 marketing authorizations in France and is handling over 30 development projects.